ABT Price / Book | ABBOTT LABORATORIES

ABBOTT LABORATORIES (ABT) Price / Book

2026-09-03: Price/Book Ratio 3.64.
2026-03-31: Price/Book Ratio 3.44.
2025-12-31: Price/Book Ratio 4.18.
2025-09-30: Price/Book Ratio 4.57.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	3.64
2026-03-31	3.44
2025-12-31	4.18
2025-09-30	4.57
2025-06-30	4.68
2025-03-31	4.73
2024-12-31	4.12
2024-09-30	4.97
2024-06-30	4.6
2024-03-31	5.09
2023-12-31	4.95
2023-09-30	4.49
2023-06-30	5.09
2023-03-31	4.76
2022-12-31	5.22
2022-09-30	4.73
2022-06-30	5.21
2022-03-31	5.85
2021-12-31	6.95
2021-09-30	6.07
2021-06-30	6.08
2021-03-31	6.34
2020-12-31	5.92
2020-09-30	6.15
2020-06-30	5.29
2020-03-31	4.62
2019-12-31	4.94
2019-09-30	4.65
2019-06-30	4.69
2019-03-31	4.56
2018-12-31	4.16
2018-09-30	4.2
2018-06-30	3.5
2018-03-31	3.35
2017-12-31	3.22
2017-09-30	2.9
2017-06-30	2.67
2017-03-31	2.46
2016-12-31	2.75
2016-09-30	3
2016-06-30	2.79
2016-03-31	2.97
2015-12-31	3.16
2015-09-30	2.84
2015-06-30	3.18
2015-03-31	3.15
2014-12-31	3.15
2014-09-30	2.74
2014-06-30	2.61
2014-03-31	2.47
2013-12-31	2.35
2013-09-30	2.17
2013-06-30	2.43
2013-03-31	2.44
2012-12-31	1.86
2012-09-30	1.92
2012-06-30	1.98
2012-03-31	1.82
2011-12-31	1.72
2011-09-30	1.55
2011-06-30	1.49
2011-03-31	1.49
2010-12-31	1.57
2010-09-30	1.81
2010-06-30	1.74
2010-03-31	1.87
2009-12-31	1.73
2009-09-30	1.72
2009-06-30	1.76

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PFIZER INC (PFE)	United States	$162.042B	31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64